Use of glucosamine and chondroitin and lung cancer risk in the VITamins and Lifestyle (VITAL) cohort

Cancer Causes and Control

Volumn 22, Issue 9, 2011, Pages 1333-1342

  Brasky, Theodore M ^a,b   Lampe, Johanna W ^a,b   Slatore, Christopher G ^c,d   White, Emily ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Chondroitin; Glucosamine; Non small cell lung cancer; Small cell lung cancer; Supplement

Indexed keywords

CHONDROITIN; GLUCOSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SMOKING;

ADENOCARCINOMA; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMOPREVENTION; CHONDROITIN; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLUCOSAMINE; HUMANS; LIFE STYLE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SMOKING; WASHINGTON;

EID: 80052326857     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9806-8     Document Type: Article

References (39)

1. JM Lee J Yanagawa KA Peebles S Sharma JT Mao SM Dubinett 2008 Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment Crit Rev Oncol Hematol 66 3 208 217 18304833 10.1016/j. critrevonc.2008.01.004
2. SA Khuder NA Herial AB Mutgi DJ Federman 2005 Nonsteroidal antiinflammatory drug use and lung cancer: a metaanalysis Chest 127 3 748 754 15764753 10.1378/chest.127.3.748 (Pubitemid 40775501)
3. Rothwell PM, Fowkes FGR, Belch JFF, Ogawa H, Warlow CP, Meade TW (2010) Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet. Epub 7 Dec 2010
4. S Bonovas A Tsantes T Drosos NM Sitaras 2008 Cancer chemoprevention: a summary of the current evidence Anticancer Res 28 3B 1857 1866 18630472 1:CAS:528:DC%2BD1cXos1yrs7s%3D (Pubitemid 351892897)
5. SD Solomon J Wittes PV Finn R Fowler J Viner MM Bertagnolli, et al. 2008 Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis Circulation 117 16 2104 2113 18378608 10.1161/CIRCULATIONAHA.108.764530 1:CAS:528:DC%2BD1cXks1Gjs7g%3D (Pubitemid 351572169)
6. MM Wolfe DR Lichtenstein G Singh 1999 Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs N Engl J Med 340 24 1888 1899 10369853 10.1056/NEJM199906173402407 1:CAS:528:DyaK1MXktFKrtbs%3D (Pubitemid 29272670)
7. JA Satia A Littman CG Slatore JA Galanko E White 2009 Associations of herbal and specialty supplements with lung and colorectal cancer risk in the VITamins and Lifestyle study Cancer Epidemiol Biomarkers Prev 18 5 1419 1428 19423520 10.1158/1055-9965.EPI-09-0038 1:CAS:528:DC%2BD1MXlsFCltrc%3D
8. M Iovu G Dumais P du Souich 2008 Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis and cartilage/OARS Osteoarthritis Res Soc 16 Suppl 3 S14 S18 10.1016/j.joca.2008.06.008
9. R Largo MA Alvarez-Soria I Diez-Ortego E Calvo O Sanchez-Pernaute J Egido, et al. 2003 Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis and cartilage/OARS Osteoarthritis Res Soc 11 4 290 298 10.1016/S1063-4584(03)00028-1 1:STN:280:DC%2BD3s7ovFSmsg%3D%3D (Pubitemid 36410882)
10. PS Chan JP Caron MW Orth 2006 Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate J Rheumatol 33 7 1329 1340 16821268 1:CAS:528: DC%2BD28XnslWjt7c%3D (Pubitemid 44025148)
11. L Zou S Yang V Champattanachai S Hu IH Chaudry RB Marchase, et al. 2009 Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling Am J Physiol Heart Circ Physiol 296 2 H515 H523 19098112 10.1152/ajpheart.01025.2008 1:CAS:528:DC%2BD1MXitVejsb0%3D
12. DM Qato GC Alexander RM Conti M Johnson P Schumm ST Lindau 2008 Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States JAMA 300 24 2867 2878 19109115 10.1001/jama.2008.892 1:CAS:528:DC%2BD1MXmtlGitQ%3D%3D
13. KM Jordan NK Arden M Doherty B Bannwarth JW Bijlsma P Dieppe, et al. 2003 EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) Ann Rheum Dis 62 12 1145 1155 14644851 10.1136/ard.2003.011742 1:STN:280: DC%2BD3srpsFGmug%3D%3D (Pubitemid 37500619)
14. E White RE Patterson AR Kristal M Thornquist I King AL Shattuck, et al. 2004 VITamins And Lifestyle cohort study: study design and characteristics of supplement users Am J Epidemiol 159 1 83 93 14693663 10.1093/aje/kwh010 (Pubitemid 38049425)
15. J Satia-Abouta RE Patterson IB King KL Stratton AL Shattuck AR Kristal, et al. 2003 Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study Am J Epidemiol 157 10 944 954 12746248 10.1093/aje/kwg039 (Pubitemid 36555055)
16. RW Field BJ Smith CE Platz RA Robinson JS Neuberger CP Brus, et al. 2004 Lung cancer histologic type in the surveillance, epidemiology, and end results registry versus independent review J Natl Cancer Inst 96 14 1105 1107 15265973 10.1093/jnci/djh189 1:STN:280:DC%2BD2czmt1KktA%3D%3D (Pubitemid 39172413)
17. CG Slatore AJ Littman DH Au JA Satia E White 2008 Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer Am J Respir Crit Care Med 177 5 524 530 17989343 10.1164/rccm.200709-1398OC 1:CAS:528:DC%2BD1cXjvFyqs78%3D (Pubitemid 351442191)
18. A Paganini-Hill A Chao RK Ross BE Henderson 1989 Aspirin use and chronic diseases: a cohort study of the elderly BMJ 299 6710 1247 1250 2513898 10.1136/bmj.299.6710.1247 1:STN:280:DyaK3c7gsFyiug%3D%3D (Pubitemid 19280046)
19. A Akhmedkhanov P Toniolo A Zeleniuch-Jacquotte KL Koenig RE Shore 2002 Aspirin and lung cancer in women Br J Cancer 87 1 49 53 12085255 10.1038/sj.bjc.6600370 1:CAS:528:DC%2BD38XkvVahs78%3D
20. S Friis HT Sorensen JK McLaughlin SP Johnsen WJ Blot JH Olsen 2003 A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin Br J Cancer 88 5 684 688 12618874 10.1038/sj.bjc. 6600760 1:STN:280:DC%2BD3s7gsFWlsQ%3D%3D (Pubitemid 36411444)
21. CN Holick DS Michaud MF Leitzmann WC Willett E Giovannucci 2003 Aspirin use and lung cancer in men Br J Cancer 89 9 1705 1708 14583773 10.1038/sj.bjc.6601343 1:CAS:528:DC%2BD3sXosVCjt78%3D (Pubitemid 37464143)
22. HT Sorensen S Friis B Norgard L Mellemkjaer WJ Blot JK McLaughlin, et al. 2003 Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study Br J Cancer 88 11 1687 1692 12771981 10.1038/sj.bjc. 6600945 1:CAS:528:DC%2BD3sXktVentLo%3D (Pubitemid 36760410)
23. MV Skriver M Norgaard AH Poulsen S Friis H Harving J Fryzek, et al. 2005 Use of nonaspirin NSAIDs and risk of lung cancer Int J Cancer 117 5 873 876 15957171 10.1002/ijc.21260 1:CAS:528:DC%2BD2MXht1ShsbfF (Pubitemid 41598842)
24. JH Hayes KE Anderson AR Folsom 2006 Association between nonsteroidal anti-inflammatory drug use and the incidence of lung cancer in the Iowa women's health study Cancer Epidemiol Biomarkers Prev 15 11 2226 2231 17119050 10.1158/1055-9965.EPI-06-0172 1:CAS:528:DC%2BD28Xht1aisrfM (Pubitemid 44877049)
25. D Feskanich C Bain AT Chan N Pandeya FE Speizer GA Colditz 2007 Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency Br J Cancer 97 9 1295 1299 17895894 10.1038/sj.bjc.6603996 1:CAS:528: DC%2BD2sXht1aqtLjF (Pubitemid 350035799)
26. S Hernandez-Diaz LA Garcia Rodriguez 2007 Nonsteroidal anti-inflammatory drugs and risk of lung cancer Int J Cancer 120 7 1565 1572 17205530 10.1002/ijc.22514 1:CAS:528:DC%2BD2sXis12isbg%3D (Pubitemid 46355395)
27. C Siemes LE Visser JW Coebergh A Hofman AG Uitterlinden BH Stricker 2008 Protective effect of NSAIDs on cancer and influence of COX-2 C(-765G) genotype Curr Cancer Drug Targets 8 8 753 764 19075598 10.2174/156800908786733414 1:CAS:528:DC%2BD1cXhsVKhsrrO
28. CG Slatore DH Au AJ Littman JA Satia E White 2009 Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study Cancer Epidemiol Biomarkers Prev 18 4 1203 1207 19293309 10.1158/1055-9965.EPI-08-1110 1:CAS:528:DC%2BD1MXktFCgsb4%3D
29. DM Schreinemachers RB Everson 1994 Aspirin use and lung, colon, and breast cancer incidence in a prospective study Epidemiology 5 2 138 146 8172988 10.1097/00001648-199403000-00003 1:STN:280:DyaK2c3islWmsw%3D%3D (Pubitemid 24073387)
30. NR Cook IM Lee JM Gaziano D Gordon PM Ridker JE Manson, et al. 2005 Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial J Am Med Assoc 294 1 47 55 10.1001/jama.294.1.47 1:CAS:528:DC%2BD2MXlvVKnt7Y%3D (Pubitemid 41002838)
31. T Hida Y Yatabe H Achiwa H Muramatsu K Kozaki S Nakamura, et al. 1998 Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas Cancer Res 58 17 3761 3764 9731479 1:CAS:528:DyaK1cXlvVyrtbk%3D (Pubitemid 28405625)
32. LM Coussens Z Werb 2002 Inflammation and cancer Nature 420 6917 860 867 12490959 10.1038/nature01322 1:CAS:528:DC%2BD38XpsFygtb4%3D (Pubitemid 36019639)
33. DO Clegg DJ Reda CL Harris MA Klein JR O'Dell MM Hooper, et al. 2006 Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis N Engl J Med 354 8 795 808 16495392 10.1056/NEJMoa052771 1:CAS:528:DC%2BD28XhslyqsrY%3D (Pubitemid 43290918)
34. J Brogger P Bakke GE Eide A Gulsvik 2003 Contribution of follow-up of nonresponders to prevalence and risk estimates: a Norwegian respiratory health survey Am J Epidemiol 157 6 558 566 12631547 10.1093/aje/kwg003 (Pubitemid 36292916)
35. G Herrero-Beaumont JA Ivorra M Del Carmen Trabado FJ Blanco P Benito E Martin-Mola, et al. 2007 Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator Arthritis Rheum 56 2 555 567 17265490 10.1002/art.22371 1:CAS:528:DC%2BD2sXislShur8%3D
36. TE McAlindon MP LaValley JP Gulin DT Felson 2000 Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis JAMA 283 11 1469 1475 10732937 10.1001/jama.283.11.1469 1:CAS:528:DC%2BD3cXit1Sms7c%3D (Pubitemid 30151826)
37. W Zhang RW Moskowitz G Nuki S Abramson RD Altman N Arden, et al. 2008 OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines Osteoarthritis Cartilage 16 2 137 162 18279766 10.1016/j.joca.2007.12.013 1:STN:280: DC%2BD1c7it12itg%3D%3D (Pubitemid 351222155)
38. Product review of joint health supplements with glucosamine, chondroitin, and/or MSM. Updated 8/2/2010-11/30/2010. Available from ConsumerLab.com
39. J Cuzick F Otto JA Baron PH Brown J Burn P Greenwald, et al. 2009 Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement Lancet Oncol 10 5 501 507 19410194 10.1016/S1470-2045(09)70035-X 1:CAS:528:DC%2BD1MXlsVKhs78%3D